Riskpilot← Back to searchSign inGet full accessDala Läkartjänster AB
ABActiveOrg 5568502768Linnévägen 3Medical specialists activities · NACE 8622Est. 20111-4 employees
Revenue 2024
SEK 561K
-8% vs 2023
EBITDA margin
67.0%
-4% vs 2023
Equity ratio
72.2%
Financial strength
Net profit 2024
SEK 220K
-24% vs 2023
| Revenue | SEK 561K | -8% |
| EBITDA | SEK 376K | -4% |
| Net profit | SEK 220K | -24% |
| Total assets | SEK 2,2M | +3% |
| Equity | SEK 1,6M | +3% |
| Employees | — | — |
Legal name
Dala Läkartjänster AB
Org number
5568502768
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
20 april 2011
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Föremålet för bolagets verksamhet är läkartjänster, främst inom allmänmedicin och hudsjukdomar och därmed förenlig verksamhet.
Address
Linnévägen 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 745 | 622 | 655 | 608 | 561 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 515 | 327 | 332 | 390 | 376 |
| Depreciation & amort. | −82 | −113 | −113 | −113 | −0 |
| EBIT | 433 | 214 | 219 | 277 | 376 |
| Net financials | −2 | — | — | 2 | 8 |
| Profit before tax | 293 | 184 | 251 | 371 | 284 |
| Tax | −67 | −40 | −55 | −81 | −64 |
| Net profit | 226 | 144 | 196 | 290 | 220 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 149 | 2 201 | 2 101 | 2 123 | 2 192 |
| Equity | 1 475 | 1 435 | 1 444 | 1 539 | 1 583 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 119 | 179 | 104 | 121 | 82 |
| Total debt | 119 | 179 | 104 | 121 | 82 |
EBITDA margin
67.0%
This company
15.8%
Market median
+324% vs market
20202024
Equity ratio
72.2%
This company
38.2%
Market median
+89% vs market
20202024
Return on equity
13.9%
This company
18.4%
Market median
+24% vs market
20202024
Net profit margin
39.2%
This company
8.1%
Market median
+384% vs market
20202024
Asset turnover
0.26×
This company
1.12×
Market median
-77% vs market
20202024
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dala Läkartjänster AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Maria Hedlund Hallander | Board of Directors | 0 companies |
| David Hans Henning Hallander | Chairman | 0 companies |
| Karin Marie-Louise Hedlund | Deputy Board Member | 0 companies |